Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.38 CAD | +3.03% | +22.05% | +466.67% |
Business Summary
Number of employees: 16
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Delphine Davan
IRC | Investor Relations Contact | - | 23-08-13 |
Minh To
PRN | Corporate Officer/Principal | - | 23-08-13 |
Eamonn Peters
PRN | Corporate Officer/Principal | - | 23-08-13 |
Evelyn Pau
PRN | Corporate Officer/Principal | - | 23-08-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Founder | - | 11-09-30 | |
Jack Geltosky
BRD | Director/Board Member | 78 | 20-09-29 |
John Sampson
BRD | Director/Board Member | - | 21-09-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,778,857 | 48,558,694 ( 64.94 %) | 0 | 64.94 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+466.67% | 121M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+47.02% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- MDNA Stock
- Company Medicenna Therapeutics Corp.